[BXRX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[BXRX] Baudax Bio, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 68.33%
YoY- -131.42%
Quarter Report
BXRX's Result
BXRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 30 -14 310 238 300 422 -
PBT -1,776 -7,301 -7,386 -9,249 -29,205 -7,531 -12,809 -73.17%
Tax 158 3,086 206 1,574 509 559 264 -28.95%
NP -1,934 -7,375 11,404 -9,249 -29,205 -7,531 -12,809 -71.61%
Tax Rate - - - - - - - -
Total Cost 1,934 7,405 -11,418 9,559 29,443 7,831 13,231 -72.21%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 -24,583.33 -81,457.14 -2,983.55 -12,271.01 -2,510.33 -3,035.31 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.24 -1.51 4.91 -5.70 -98.70 -41.95 -79.89 -97.91%
EPS Diluted -0.24 -1.51 4.91 -5.70 -98.70 -41.95 -79.89 -97.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.